Trials / Unknown
UnknownNCT02973945
High Flow Nasal Cannula and Aerobic Capacity Training
High Flow Nasal Cannula Versus The Venturi Mask During Exercise Training in Chronic Obstructive Pulmonary Disease Patients, a Randomized, Simple Blind, Controlled Trial.
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- Sponsor
- Hospital Italiano de Buenos Aires · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to compare exercise capacity in Chronic Obstructive Pulmonary Disease (COPD) patients before and after an 8 week pulmonary rehabilitation program. Patients will be randomised in two groups, one arm will received oxygen through High Flow Nasal Cannula (HFNC) and the other group by The Venturi Mask (VM)
Detailed description
Design: randomized, single blind, controlled trial. The main goal of this study is to compare the exercise tolerance in COPD patients after an 8 week pulmonary rehabilitation program using High Flow Nasal Cannula or The Venturi Mask. The exercise tolerance will be measured in seconds in a Constant Load Treadmill Test (CTLT).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | High Flow Nasal Cannula | During the pulmonary rehabilitation program, patients will train the aerobic capacity on a treadmill. Patients in the intervention arm will receive oxygen trough High Flow Nasal Cannula (HFNC) at 50 lpm and 40% of oxygen. The aerobic capacity training plan will be conducted three times a week over 24 sessions. |
| DEVICE | The Venturi Mask | During the pulmonary rehabilitation program, patients will train the aerobic capacity on a treadmill. Patients in the control arm will receive oxygen trough The Venturi Mask (VM) at 40% of oxygen. The aerobic capacity training plan will be conducted three times a week over 24 sessions. |
Timeline
- Start date
- 2017-07-01
- Primary completion
- 2019-03-01
- Completion
- 2019-05-01
- First posted
- 2016-11-28
- Last updated
- 2017-11-20
Locations
1 site across 1 country: Argentina
Source: ClinicalTrials.gov record NCT02973945. Inclusion in this directory is not an endorsement.